(Q47745405)

English

Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

0 references

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

Torsten Haferlach

11

object named as

T Haferlach

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

Claudia Haferlach

9

object named as

C Haferlach

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

Susanne Schnittger

10

object named as

S Schnittger

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

author name string

A Kohlmann

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

N Nadarajah

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

T Alpermann

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

V Grossmann

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

S Schindela

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

F Dicker

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

A Roller

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

W Kern

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

publication date

20 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

28

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

129-137

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

Regulation of TMPRSS6 by BMP6 and iron in human cells and mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Assessment of minimal residual disease in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Mutation in TET2 in myeloid cancers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Next-generation sequencing - feasibility and practicality in haematology

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Recurring mutations found by sequencing an acute myeloid leukemia genome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

DNMT3A Mutations in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

The origin and evolution of mutations in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Integration of next-generation sequencing into clinical practice: are we there yet?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

R453Plus1Toolbox: an R/Bioconductor package for analyzing Roche 454 Sequencing data

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Database resources of the National Center for Biotechnology Information

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

MutationTaster evaluates disease-causing potential of sequence alterations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

A method and server for predicting damaging missense mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

A novel hierarchical prognostic model of AML solely based on molecular mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

Robustness of Amplicon Deep Sequencing Underlines Its Utility in Clinical Applications

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.239

21 January 2018

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Landscape of TET2 mutations in acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/23958918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/LEU.2013.239

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23958918

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47745405&oldid=2208806069"